Skip to content

5-MeO-DMT: all studies

Page 69 of 110: studies 681 to 690 of 1,097, newest first. Back to the 5-MeO-DMT overview

Research

On the application of Machine Learning and Complex Networks to Neuroscience

May 5, 2023 Caroline L. Alves

Data mining and knowledge discovery is a research area with applications in various fields, such as medicine. Data mining methods have proven to be very effective in making automated diagnoses and help medical teams in decision making. In addition to using data mining, medical data can be represented by complex networks. In the case of the brain, for example, brain regions can be represented as...

Microbiota-derived psychedelics: Lessons from COVID-19.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University April 1, 2023 Adonis Sfera, Sabine Hazan, Zisis Kozlakidis et al. 7 citations

Emil Kraepelin believed that dementia praecox, the disorder we now call schizophrenia, was caused by the brain being poisoned with toxins generated in other parts of the body, especially the mouth, intestine or genitals. In this regard, Kraepelin hinted at the microbiome and conceptualized microbial molecules as drivers of severe psychiatric illness. However, it was not until the coronavirus...

DOI: 10.17219/acem/159477 (opens in new tab) Full text (opens in new tab) Gut microbes Serotonergic hallucinogens Severe psychiatric illness Gut bacteria +5

Human brain effects of DMT assessed via EEG-fMRI.

Proceedings of the National Academy of Sciences March 28, 2023 Christopher Timmermann, Leor Roseman, Sharad Haridas et al. 217 citations

Psychedelics have attracted medical interest, but their effects on human brain function are incompletely understood. In a comprehensive, within-subjects, placebo-controlled design, we acquired multimodal neuroimaging [i.e., EEG-fMRI (electroencephalography-functional MRI)] data to assess the effects of intravenous (IV) N,N-Dimethyltryptamine (DMT) on brain function in 20 healthy volunteers....

Neural Network Modulation of Ayahuasca: A Systematic Review of Human Studies

Psychoactives March 20, 2023 Guilherme Henrique de Morais Santos, Lucas Silva Rodrigues, Juliana Mendes Rocha et al. 6 citations

Background: Ayahuasca is a serotoninergic hallucinogen that plays a central role in the Amazonian traditional medicine. Its psychoactive effects are associated with the presence of N,N-dimethyltryptamine (DMT), and monoamine oxidase inhibitors (MAO-A). Advances in neuroimaging investigations have provided insight into ayahuasca’s neurobiological mechanisms of action. Methods: Selecting only...

Ayahuasca in the treatment of bipolar disorder with psychotic features–A retrospective case study

March 10, 2023 Mika Turkia 1 citation preprint

Ayahuasca is a plant-based brew of indigenous Amazonian origin. It has psychedelic, anti-inflammatory, neuroprotective, cytotoxic, and anti-parasitic effects, which are primarily due to monoamine oxidase inhibitors (MAOIs) and N,N-dimethyltryptamine (DMT). This article describes the case of a woman in her late thirties with complex trauma due to severe, years-long sexual abuse in early...

DOI: 10.31234/osf.io/65se9 (opens in new tab) Full text (opens in new tab) Ayahuasca Bipolar disorder Borderline personality disorder Sexual abuse +1

Bioproduction platform using a novel cane toad (Rhinella marina) N-methyltransferase for psychedelic-inspired drug discovery

Research Square March 10, 2023 Xue Chen, Jing Li, Lisa Yu et al. preprint

Abstract Psychedelic indolethylamines have emerged as potential medicines to treat several psychiatric pathologies. Natural sources of these compounds include ‘magic mushrooms’, plants used to prepare ahayuasca, and toads. Owing to the occurrence of indolethylamines such as N,N-dimethyltryptamine, toad skin and parotid gland preparations have a history of ceremonial use, yet their biosynthesis...

Intersecting Cultures

February 27, 2023 Emma Garrod, Katrina Blommaert 2 citations

Ayahuasca has experienced a meandering legal and ethical journey in Canada. The health and spiritual benefits of this medicine are profound, yet it is paramount to consider the implications of its use in places far removed from its endemic regions. In Canada, under the Controlled Drugs and Substances Act (CDSA), N,N-dimethyltryptamine (DMT) and harmaline, two ingredients in ayahuasca, are both...

Characterization of the Binding Poses of Classical and Photoswitchable Psychedelics Interacting with 5-HT2AR

ChemRxiv February 7, 2023 Vito F. Palmisano, Claudio Agnorelli, David Erritzøe et al. 1 citation preprint

Classic psychedelics are compounds that target the 5-hydroxytryptamine receptor type 2A (5-HT2AR), inducing profound changes in consciousness. Although these compounds most closely resemble the natural neurotransmitter serotonin, their therapeutic and psychoactive action is still not well understood. Therefore, a quantitative atomistic description of their interaction in the 5-HT2AR receptor is...

Bufo Rana in Homeopathy: Potentization, Toxicology, Clinical Consequences, and Therapeutic Use

Ars medica tomitana February 1, 2023 Geir Bjørklund, Olha Storchylo

Abstract Homeopathy, an alternative treatment method based on the principle of “like cures like,” has gained attention in recent years. This paper focuses on Bufo Rana, a homeopathic remedy prepared from the poison of the Bufo toad. We explore the process of potentization and dosage in homeopathy, discussing the various potencies and the influence of Avogadro’s number. Furthermore, we provide...

DOI: 10.2478/arsm-2023-0005 (opens in new tab) Homeopathy Bufo Materia medica Traditional medicine +8

Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter.

Journal of Pharmacology and Experimental Therapeutics January 20, 2023 Laura B. Kozell, Amy J. Eshleman, Tracy L. Swanson et al. 40 citations

Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter.

DOI: 10.1124/jpet.122.001454 (opens in new tab) Full text (opens in new tab) Drug design Medicinal chemistry Therapeutics Neuropharmacology: psychopharmacology +7